Strata Critical Medical SRTA Other Clinical — Revenue

Other product segments

Similar metrics at other companies

WWClinical Subscription Revenues — Revenue

$39.91M+38.3%

TEMClinical Order — Revenue

$239.3M+31.8%

SLPClinical Operations — Revenue

$277K-33.4%

MMSClinical Services — Revenue

$553.08M-1.3%

MLABClinical Genomics — Revenue

$10.29M-0.1%

BLLNClinical trial support and other services — Revenue

$1.54M+98.6%

FAQ

What is Strata Critical Medical's other clinical — revenue?

Strata Critical Medical (SRTA) reported other clinical — revenue of $9.95M in Q1 2026.

What does other clinical — revenue mean?

This metric represents the total revenue generated from the company's 'Other Clinical' business segment, which encompasses specialized medical products or services outside of the primary core offerings. It serves as a key indicator of the company's ability to diversify its clinical portfolio and capture value from niche or emerging medical markets. Tracking this revenue stream helps investors assess the contribution of secondary clinical activities to the overall top-line growth and business diversification strategy.